ATARAX
Manufacturer Details
DR.REDDYS
Compositions:
Hydroxyzine hcl 10mg/25mg TABLETS,
Hydroxyzine hcl 10mg/5ml SYRUP,
Hydroxyzine hcl 6mg per ml -DROPS,
|
Strength
|
Rate
|
Packing Style
|
|
10mg
|
43.56
|
15s TABLETS
|
|
25mg
|
64.50
|
15s TABLETS
|
|
10mg/5ml
|
100.25
|
100ml SYRUP
|
|
6mg/ml
|
52.50
|
15ml DROPS
|
List of Related Indications:
List Of Drugs:
- Hydroxyzine@( ** )- Antianxiety agent- (Aug 2010)
Indication Type Description:
Drug Interaction:
Antiemetics/ Antivertigo agents- include Phenothiazines- Chlorpromazine Nausea /Vomiting Triflupromazine Nausea /Vomiting Perphenazine Nausea /Vomiting Promethazine Nausea /Vomiting Motion Sickness Prochlorperazine Nausea /Vomiting Others- Metoclopramide Nausea /Vomiting Anticholinergics- Antihistamines- Cyclizine Nausea /Vomiting Motion Sickness Meclizine Nausea /Vomiting Motion Sickness Vertigo Buclizine Motion Sickness Diphenhydramine Nausea /Vomiting Motion Sickness Vertigo Dimenhydrinate Nausea /Vomiting Motion Sickness Verigo Others- Trimethobenzamide Nausea /Vomiting Scopolamine Motion sickness Miscellaneous- Diphenidol Nausea /Vomiting Vertigo Benzquinamide Nausea /Vomiting Phosphated carbh } Nausea /Vomiting hydrated solution } Hydroxyine Nausea /Vomiting Corticosteroids Nausea /Vomiting Cannabinoids Nausea /Vomiting Refer Chlorpromazine
Indication:
New drugs approved For Marketing by Drug Controller General of India(DCGI )
during the period January 1988 to November 2014
(Ref- IDMA Annual Publication 2015)
Name of Drug Indication Date of Approval
Hydroxyzine hydrochloride 20-08-2010
SR Tablets 25/50/75mg
For the management of pruritus due to allergic conditions such as
chronic urticaria, and atopic contact dermatoses and in histamine-
mediated pruritus
Adverse Reaction:
CNS depression,paradoxical CNS stimulation(chidren), dry mouth, thickened respiratory secretions, constipation, urinary retension, blurring of vision, bradycardia,followed by tachycardia and arrythmias, GI disturbances,blood dyscrasias, headache, giddiness, hypotension, tinnitus and confusion.
Contra-Indications:
Pregnancy,lactation,neonates,obstruction of GIT,urinary outflow,paralytic ileus.
Special precautions:
Renal impairment,nmay impair judgement and dexterity.
Lactation,CVS disease, glaucoma, epilepsy, peptic ulcer,BHP.
Dosages/ Overdosage Etc:
Date of Approval 2010
Indications:
Symptomatic relief of anxiet and tension.
Dosage:
Oral Adults- 50 to 100mg 4 times a day.
Children(Below 6 years)- 50mg in divided doses. Children(above 6 years ) 50 to 100mg/day in divided doses.
Patient Information:
Antiemetics/ Antivertigo agents- include Phenothiazines- Chlorpromazine Nausea /Vomiting Triflupromazine Nausea /Vomiting Perphenazine Nausea /Vomiting Promethazine Nausea /Vomiting Motion Sickness Prochlorperazine Nausea /Vomiting Others- Metoclopramide Nausea /Vomiting Anticholinergics- Antihistamines- Cyclizine Nausea /Vomiting Motion Sickness Meclizine Nausea /Vomiting Motion Sickness Vertigo Buclizine Motion Sickness Diphenhydramine Nausea /Vomiting Motion Sickness Vertigo Dimenhydrinate Nausea /Vomiting Motion Sickness Verigo Others- Trimethobenzamide Nausea /Vomiting Scopolamine Motion sickness Miscellaneous- Diphenidol Nausea /Vomiting Vertigo Benzquinamide Nausea /Vomiting Phosphated carbh } Nausea /Vomiting hydrated solution } Hydroxyine Nausea /Vomiting Corticosteroids Nausea /Vomiting Cannabinoids Nausea /Vomiting Refer Chlorpromazine
1.May produce drowsiness,patients should observe caution while driving or performing other tasks requiring alertness.
2.Avoid alcohol or other CNS depressants, that may intensify this effect..
Interaction with Food:
Not known.
Pregnancy and lactation:
Use contraindicated Observe caution
